Metabolic Shifts & Cardiovascular Foundations: The Expanding Role of SGLT2i Inhibitors Tags SGLT-2 Inhibitor Read more about Metabolic Shifts & Cardiovascular Foundations: The Expanding Role of SGLT2i Inhibitors
Dapagliflozin Added to Valsartan Improved Cardiorenal Measures in T2DM Tags SGLT-2 Inhibitor Read more about Dapagliflozin Added to Valsartan Improved Cardiorenal Measures in T2DM
TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM Tags Myocardial infarction Peripheral vascular disease Stroke DPP-4 inhibitors Thiazolidinediones Read more about TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM
Oral Semaglutide 25 mg Matched SC Exposure in Obesity With and Without T2DM Tags GLP-1 agonists Read more about Oral Semaglutide 25 mg Matched SC Exposure in Obesity With and Without T2DM
Petrelintide Showed Weight Loss With Low GI Events Tags Amylin analogue Read more about Petrelintide Showed Weight Loss With Low GI Events
One-Hour OGTT Glucose Identified More Diabetes Cases Tags ORAL GTT Read more about One-Hour OGTT Glucose Identified More Diabetes Cases
SGLT2 Inhibitors Reduced Rejection After Heart Transplant Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Reduced Rejection After Heart Transplant
Tirzepatide Outperformed Dulaglutide for MACE in T2DM With ASCVD Tags Coronary artery disease GLP-1 agonists Read more about Tirzepatide Outperformed Dulaglutide for MACE in T2DM With ASCVD
NAION Risk Increased After GLP-1 RA Start in T2DM Tags Nonarteritic Ischemic Optic Neuropathy GLP-1 agonists DPP-4 inhibitors Read more about NAION Risk Increased After GLP-1 RA Start in T2DM
Antibiotics in Pregnancy and Infancy Not Tied to T1DM Overall Tags Antibiotics Caeserian Section Read more about Antibiotics in Pregnancy and Infancy Not Tied to T1DM Overall